Home  >  Products  >  UBQLN2 (ubiquilin 2) Blocking Peptide (the N terminal of UBQLN2)(100ug)
UBQLN2 (ubiquilin 2) Blocking Peptide (the N terminal of UBQLN2)(100ug)

UBQLN2 (ubiquilin 2) Blocking Peptide (the N terminal of UBQLN2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-UBQLN2 Antibody, made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59353
Size: 100ug
Weight: 66kDa
Gene: 29978
Format: Lyophilized powder
Target: This gene encodes an ubiquitin-like protein (ubiquilin) that shares high degree of similarity with related products in yeast, rat and frog. Ubiquilins contain a N-terminal ubiquitin-like domain and a C-terminal ubiquitin-associated domain. They physically associate with both proteasomes and ubiquitin ligases; and thus, are thought to functionally link the ubiquitination machinery to the proteasome to affect in vivo protein degradation. This ubiquilin has also been shown to bind the ATPase domain of the Hsp70-like Stch protein.
Alternative names: CHAP1; DSK2; FLJ10167; FLJ56541; HRIHFB2157; N4BP4; PLIC2
See Full Product Listings >